Selective targeting of antiapoptotic BCL-2 proteins in cancer

Medicinal Research Reviews
Ahmet Can TimucinOzgur Kutuk

Abstract

Circumvention of apoptotic machinery is one of the distinctive properties of carcinogenesis. Extensively established key effectors of such apoptotic bypass mechanisms, the antiapoptotic BCL-2 (apoptosis regulator BCL-2) proteins, determine the response of cancer cells to chemotherapeutics. Within this background, research and development of antiapoptotic BCL-2 inhibitors were considered to have a tremendous amount of potential toward the discovery of novel pharmacological modulators in cancer. In this review, milestone achievements in the development of selective antiapoptotic BCL-2 proteins inhibitors for BCL-2, BCL-XL (BCL-2-like protein 1), and MCL-1 (induced myeloid leukemia cell differentiation protein MCL-1) were summarized and their future implications were discussed. In the first section, the design and development of BCL-2/BCL-XL dual inhibitor navitoclax, as well as the recent advances and clinical experience with selective BCL-2 inhibitor venetoclax, were synopsized. Preclinical data from selective BCL-XL inhibitors, which are currently undergoing extensive testing as a single agent or in combination with other therapeutic agents, were further summarized. In the second section, MCL-1 inhibitors developed as potential...Continue Reading

References

Jun 21, 1985·Science·Y TsujimotoC M Croce
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
May 29, 2002·Oncogene·Shinichi KitadaJohn C Reed
Jun 1, 2002·Science·Harald Wajant
Dec 12, 2003·Nature·Joseph T OpfermanStanley J Korsmeyer
Mar 5, 2004·Biochimica Et Biophysica Acta·Andrew M PetrosStephen W Fesik
Apr 13, 2004·Oncogene·Xavier SaelensPeter Vandenabeele
Apr 23, 2004·The EMBO Journal·Michelle M HillSeamus J Martin
Nov 3, 2004·Nature Reviews. Molecular Cell Biology·Claudia WellbrockRichard Marais
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Nov 18, 2005·Journal of Hepatology·Wolfgang SieghartVolker Wacheck
Jun 10, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·David HuiRaymond Lai
Jan 30, 2007·Journal of Medicinal Chemistry·Milan BrunckoSteven W Elmore
Feb 22, 2007·British Journal of Cancer·C-L ChenJ Lin
Mar 27, 2007·Cell·Kylie D MasonBenjamin T Kile
Jul 27, 2007·Oncogene·K PodarK C Anderson
Nov 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mai NguyenGordon C Shore
Dec 7, 2007·Blood·Victoria Del Gaizo MooreAnthony Letai
May 3, 2008·Cancer Research·Christin TseSteven W Elmore
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex R ShoemakerSteven W Elmore
Jun 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ivan DzhagalovYou-Wen He
Jun 24, 2008·Molecular Cell·Yongjie WeiBeth Levine
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Sep 23, 2008·Cell Death and Differentiation·M VoglerG M Cohen

❮ Previous
Next ❯

Citations

Mar 29, 2019·Cellular Oncology (Dordrecht)·In-Hyoung YangSung-Dae Cho
Apr 7, 2020·International Journal of Cancer. Journal International Du Cancer·Hsin-Yi TsengStuart Gallagher
May 31, 2020·International Journal of Molecular Sciences·Isshin ShiibaShigeru Yanagi
Sep 10, 2020·Apoptosis : an International Journal on Programmed Cell Death·Sehime Gulsun TemelOzgur Kutuk
Dec 14, 2018·International Journal of Molecular Sciences·Marilina García-ArandaMaximino Redondo
Dec 20, 2019·Blood Advances·Anne SlompVictor Peperzak
Oct 13, 2020·Frontiers in Cell and Developmental Biology·Samara Naim, Thomas Kaufmann
Oct 30, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Wan-Qiong HuangWen-Xiu Ni
Dec 1, 2020·Bioorganic & Medicinal Chemistry Letters·Kexue Li
Dec 1, 2020·Frontiers in Oncology·Yunxiong WeiMingfeng Zhao
Dec 28, 2019·Current Protein & Peptide Science·Chen ZhengJing Wang
Jun 26, 2021·The International Journal of Biochemistry & Cell Biology·Yeliz AkaOzgur Kutuk
Jul 28, 2021·Dalton Transactions : an International Journal of Inorganic Chemistry·Junmiao WuFeng Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.